Clinical trial Recruiting at 1 site Observational Ages 18 and up

Cohort study to observe asthma outcomes in China

Official title: The Cohort Study for Asthma in China: an Prospective Observational Study

Run by Beijing Chao Yang Hospital · NCT05937334 · Data updated 2026-11-12

This study is trying to learn more about asthma by following 400 patients in China for two years to see how their condition changes and what factors might affect their outcomes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorBeijing Chao Yang Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJuly 10, 2023
Trial IDNCT05937334 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 who meet the 2023 GINA diagnostic criteria for asthma and can commit to a two-year follow-up.

Probably not a fit

Patients with severe lung diseases, recent surgeries, or other serious uncontrolled conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a standardized asthma cohort of 400 patients in China, collecting baseline data through various diagnostic tests such as lung function tests and chest CT scans. Participants will be followed for at least two years to observe asthma outcomes and identify biomarkers that may predict these outcomes. The study will utilize an electronic data capture system and involve statistical analysis by a specialized work group from the Chinese Academy of Sciences. No investigational drugs will be administered, focusing instead on understanding the mechanisms of asthma pathogenesis.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of asthma, potentially identifying biomarkers that help predict patient outcomes.

How similar studies have gone: Other studies have shown success in establishing asthma cohorts and identifying biomarkers, making this approach both relevant and promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18
* Meet the 2023 edition of GINA asthma diagnostic criteria
* Subjects must sign informed consent prior to study participation, participate in the study according to the protocol and follow up for 2 years

Exclusion Criteria:

* Suffering from other massive lung tissue destructive diseases such as severe bronchiectasis and tuberculosis
* Severe pleural disease and/or sternal and rib lesions
* Serious uncontrolled disease of other system
* Thoracic or abdominal surgery in the past 3 months
* Eye surgery in the past three months
* Retina detachment
* Myocardial infarction within the last 3 months
* Hospitalized for heart disease within the past 3 months
* Ongoing anti-tuberculosis treatment
* Pregnancy or breast feeding

Where it's running

  • Beijing Chao Yang Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.